|
WHWK Whitehawk Therapeutics Inc 1422142 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-22,194,000.00 |
| Balance Sheet |
|
Current Assets
|
$125,548,000.00 |
|
Assets
|
$127,231,000.00 |
|
Current Liabilities
|
$11,056,000.00 |
|
Liabilities
|
$11,056,000.00 |
|
Equity
|
$116,175,000.00 |
|
Shares Out
|
47196564.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-22,208,000.00 |
|
Investing Cash Flow
|
$19,430,000.00 |
| Market Analysis |
Market Cap
|
$181,706,771.40 |
|
Price
|
$3.81 |
|
BVPS
|
2.46 |
|
PB
|
1.57 |
|
EPS
|
-0.32 |
|
FCF
|
$-22,208,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.34 |
|
|
2026-05-07 |
-0.32 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.76 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view WHWK documents filed with the SEC.
WHWK Filings
Clear
